FDA Approves Iron-Based Contrast Agent for Brain MRI

The iron-based brain MRI contrast agent Ferabright (ferumoxytol injection) is indicated for adult patients with known or suspected malignant neoplasms.

Read the full article on diagnosticimaging.com